| Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study C Xu, T Yu, L Furuya-Kanamori, L Lin, L Zorzela, X Zhou, H Dai, Y Loke, ... Bmj 377, 2022 | 46 | 2022 |
| Insights into modifiable risk factors of infertility: A mendelian randomization study W Xu, Y You, T Yu, J Li Nutrients 14 (19), 4042, 2022 | 21 | 2022 |
| How good are large language models for automated data extraction from randomized trials? Z Sun, R Zhang, SA Doi, L Furuya-Kanamori, T Yu, L Lin, C Xu medRxiv, 2024.02. 20.24303083, 2024 | 11 | 2024 |
| The SMART Safety: an empirical dataset for evidence synthesis of adverse events S Fan, T Yu, X Yang, R Zhang, L Furuya-Kanamori, C Xu Data in Brief 51, 109639, 2023 | 4 | 2023 |
| Synthesizing evidence from the earliest studies to support decision‐making: To what extent could the evidence be reliable? T Yu, L Lin, L Furuya‐Kanamori, C Xu Research synthesis methods 13 (5), 632-644, 2022 | 3 | 2022 |
| Accelerating evidence synthesis for safety assessment through ClinicalTrials. gov platform: a feasibility study T Yu, X Yang, J Clark, L Lin, L Furuya-Kanamori, C Xu BMC Medical Research Methodology 24 (1), 165, 2024 | | 2024 |
| Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi) C Xu, L Furuya-Kanamori, L Lin, L Zorzela, T Yu, S Vohra BMC Medical Research Methodology 23 (1), 61, 2023 | | 2023 |
